Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population

European Radiology

Volumn 26, Issue 6, 2016, Pages 1895-1904

  Hetterich, Holger ^a   Bayerl, Christian ^a   Peters, Annette ^b   Heier, Margit ^b,c   Linkohr, Birgit ^b   Meisinger, Christa ^b,c   Auweter, Sigrid ^a   Kannengießer, Stephan A R ^d   Kramer, Harald ^a,e   Ertl Wagner, Birgit ^a   Bamberg, Fabian ^a,f  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c KLINIKUM AUGSBURG   (Germany)

^d SIEMENS AG   (Germany)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Dual echo Dixon; Magnetic resonance imaging; Magnetic resonance spectroscopy; Multi echo Dixon; Non alcoholic fatty liver disease

Indexed keywords

PROTON;

ADULT; AGED; ARTICLE; BREATH HOLDING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DUAL ECHO DIXON; FAT CONTENT; FATTY LIVER; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE RECONSTRUCTION; INFORMED CONSENT; LIVER; LIVER SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MIDDLE AGED; MULTI ECHO DIXON; MULTI ECHO SPECTROSCOPY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; VOXEL BASED MORPHOMETRY; ASYMPTOMATIC DISEASE; DIAGNOSTIC IMAGING; PROCEDURES; REPRODUCIBILITY;

ADULT; AGED; ASYMPTOMATIC DISEASES; FATTY LIVER; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84940853307     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-3966-y     Document Type: Article

References (30)

1. Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142:1592–1609
2. Cusi K (2009) Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 16:141–149
3. Lee JY, Kim KM, Lee SG et al (2007) Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 47:239–244
4. Marcos A, Fisher RA, Ham JM et al (2000) Selection and outcome of living donors for adult to adult right lobe transplantation. Transplantation 69:2410–2415
5. Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285
6. Williams CD, Stengel J, Asike MI et al (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124–131
7. Browning JD, Szczepaniak LS, Dobbins R et al (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387–1395
8. Machado M, Marques-Vidal P, Cortez-Pinto H (2006) Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol 45:600–606
9. OECD (2014) Obesity update 2014. OECD, Paris. http://www.oecd.org/health/Obesity-Update-2014.pdf. Accessed 26 Oct 2014
10. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F (2009) Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 51:433–445
11. Bohte AE, van Werven JR, Bipat S, Stoker J (2011) The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21:87–97
12. Bashir MR, Merkle EM, Smith AD, Boll DT (2012) Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination. Eur J Radiol 81:e101–e109
13. Bashir MR, Zhong X, Dale BM, Gupta RT, Boll DT, Merkle EM (2013) Automated patient-tailored screening of the liver for diffuse steatosis and iron overload using MRI. AJR Am J Roentgenol 201:583–588
14. Zhong X, Nickel MD, Kannengiesser SA, Dale BM, Kiefer B, Bashir MR (2014) Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging. Magn Reson Med 72:1353–1365
15. Bashir MR, Zhong X, Nickel MD et al (2015) Quantification of hepatic steatosis with a multistep adaptive fitting MRI approach: prospective validation against MR spectroscopy. AJR Am J Roentgenol 204:297–306
16. Pineda N, Sharma P, Xu Q, Hu X, Vos M, Martin DR (2009) Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy–a rapid and accurate technique. Radiology 252:568–576
17. Fischer MA, Raptis DA, Montani M et al (2012) Liver fat quantification by dual-echo MR imaging outperforms traditional histopathological analysis. Acad Radiol 19:1208–1214
18. Tang A, Desai A, Hamilton G et al (2015) Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274:416–425
19. Yokoo T, Bydder M, Hamilton G et al (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 251:67–76
20. Meisamy S, Hines CD, Hamilton G et al (2011) Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 258:767–775
21. Tang A, Tan J, Sun M et al (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267:422–431
22. Xiang QS, An L (1997) Water-fat imaging with direct phase encoding. J Magn Reson Imaging 7:1002–1015
23. Ma J (2004) Breath-hold water and fat imaging using a dual-echo two-point Dixon technique with an efficient and robust phase-correction algorithm. Magn Reson Med 52:415–419
24. Yu H, Reeder SB, Shimakawa A, Brittain JH, Pelc NJ (2005) Field map estimation with a region growing scheme for iterative 3-point water-fat decomposition. Magn Reson Med 54:1032–1039
25. DeFilippis AP, Blaha MJ, Martin SS et al (2013) Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 227:429–436
26. Baumeister SE, Volzke H, Marschall P et al (2008) Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology 134:85–94
27. Koehler EM, Schouten JN, Hansen BE et al (2012) Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol 57:1305–1311
28. German National Cohort (GNC) Consortium (2014) The German National Cohort: aims, study design and organization. Eur J Epidemiol 29:371–382
29. Henninger B, Zoller H, Rauch S et al (2015) Automated two-point Dixon screening for the evaluation of hepatic steatosis and siderosis: comparison with R2-relaxometry and chemical shift-based sequences. Eur Radiol 25:1356–1365
30. Kukuk GM, Hittatiya K, Sprinkart AM et al (2015) Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis. Eur Radiol. doi:10.1007/s00330-015-3703-6